Outcomes of Renal Transplant Recipients after Percutaneous Coronary Intervention
| Autor: | Hiroyuki Arashi, Natsuko Satomi, Yusuke Inagaki, Kentaro Jujo, Nobuhisa Hagiwara, Suguru Ebihara, Kazuki Tanaka, Hisao Otsuki, Masashi Nakao, Junichi Yamaguchi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment 030232 urology & nephrology 030204 cardiovascular system & hematology 03 medical and health sciences Percutaneous Coronary Intervention Postoperative Complications 0302 clinical medicine Renal Dialysis Internal medicine medicine Humans Kidney transplantation Aged Retrospective Studies business.industry Incidence (epidemiology) Percutaneous coronary intervention Retrospective cohort study Middle Aged medicine.disease Kidney Transplantation Transplantation Treatment Outcome surgical procedures operative Conventional PCI Propensity score matching Cardiology Kidney Failure Chronic Female Hemodialysis Cardiology and Cardiovascular Medicine business |
| Zdroj: | The American Journal of Cardiology. 125:1305-1311 |
| ISSN: | 0002-9149 |
| Popis: | Renal transplantation (RT) can improve life expectancy in hemodialysis (HD) patients. However, little is known about the outcomes of renal transplant recipients after percutaneous coronary intervention (PCI). This study aimed to elucidate the effect of RT on clinical outcomes after PCI. Renal transplant recipients who underwent PCI from 2002 to 2017 were enrolled. To evaluate the effectiveness of RT, we retrospectively reviewed HD patients who underwent PCI. Propensity-score matching was performed using logistic regression to control for differences in baseline characteristics. The primary outcome was the incidence of major adverse cardiac events. After propensity matching, patients were classified into the RT (n = 50) group and HD (n = 50) group. Kaplan-Meier analysis revealed that the incidence of major adverse cardiac events was significantly lower in the RT group than in the HD group (p0.0001). Moreover, RT was associated with a lower risk for all-cause death (odds ratio 0.04; 95% confidence interval 0.002 to 0.03; p = 0.0054) and target vessel revascularization (OR 0.27; 95% CI 0.07 to 0.79; p = 0.015). RT may improve clinical outcomes after PCI, and it is encouraged for HD patients to increase life expectancy and reduce the occurrence of adverse events after PCI. Further research would be warranted to support this finding. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect